Pricing Log in Create free account

Imunon, Inc. (IMNN) vs Senti Biosciences, Inc. (SNTI)

Imunon, Inc. and Senti Biosciences, Inc. are both Biotechnology companies. Imunon, Inc. and Senti Biosciences, Inc. are of similar size ($5.1M and $5.1M). Imunon, Inc. grew revenue faster over the last twelve months: 0.00% against −70.7%. Imunon, Inc. has the higher net margin (0.00% vs −3,789.3%) and the lower return on invested capital (−324.4% vs 0.00%). Across the 16 metrics below, Senti Biosciences, Inc. leads on 9 and Imunon, Inc. on 7.

Valuation

Metric IMNN SNTI Biotechnology median
P/E n/m n/m 10.60
P/S 8.90 3.81 9.40
P/B 2.30 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.03 0.66
EV/Sales 6.23 (1.10) 9.02
Earnings yield (450.59%) (1,106.25%) (32.88%)
Free cash flow yield (341.72%) (761.30%) (23.13%)

Profitability

Metric IMNN SNTI Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% (4,181.12%) 0.00%
Net margin 0.00% (3,789.30%) 0.00%
Free cash flow margin 0.00% (2,900.38%) 0.00%
Return on equity (641.02%) (466.46%) (51.96%)
Return on assets (123.93%) (97.52%) (46.06%)
Return on invested capital (324.37%) 0.00% 0.00%

Growth

Metric IMNN SNTI Biotechnology median
Revenue growth (TTM) 0.00% (70.73%) 6.76%
EPS growth (last fiscal year) 59.68% 77.31% 29.88%
Revenue growth, 5-year CAGR 0.00% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric IMNN SNTI Biotechnology median
Debt to equity 1.32 0.00 0.00
Current ratio 1.82 0.83 4.97
Net debt to EBITDA 0.63 0.25 1.01

Dividend

Metric IMNN SNTI Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IMNN SNTI Biotechnology median
Market cap 5.05m 5.12m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack